The virtual COPD visit during COVID-19The facts about COVID-19 and COPD and guidance on how to conduct a virtual visit Bristol-Myers Squibb discontinues Coumadin brand of warfarinGeneric alternatives still marketed, but some strengths of one generic product currently in short supply Being taken seriously Young MDs often have their judgment questioned by colleagues and patients; here’s how some deal with that NS to cover extra dispensing fees arising from 30-day prescription limits As NS steps up, the OPA and CARP have been lobbying Ontario to do the same Amputations, organ failure, blood clotting: the range of complications in COVID-19 cases Canadian interim guidelines for managing patients with moderate to severe COVID-19 Provide advice on timely, effective and safe supportive management of adults and children with suspected or confirmed COVID-19 Considerations for pharmacy owners/managers during COVID-19 The CPhA and Neighbourhood Pharmacies have developed a list of considerations if staff become ill or pharmacies need to close Oncology drugs are largest category in pipeline, review board reports Strategies for managing the shortage of salbutamol inhalers Canadian Thoracic Society issues guidance for managing patients with asthma and COPD during salbutamol inhaler shortage Majority of US independent pharmacies need coronavirus small business aid Pandemic costs final straw after years of reimbursement and cash flow declines First Previous 410 411 412 413 414 Next Last
